BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8040330)

  • 21. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.
    Burdach S; Zessack N; Dilloo D; Shatsky M; Thompson D; Levitt L
    J Clin Invest; 1991 Jun; 87(6):2114-21. PubMed ID: 1828253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA; Kipps TJ
    Cell Immunol; 1995 Apr; 161(2):226-35. PubMed ID: 7535196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.
    Lotz M; Tsoukas CD; Robinson CA; Dinarello CA; Carson DA; Vaughan JH
    J Clin Invest; 1986 Sep; 78(3):713-21. PubMed ID: 3091636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.
    Ferran C; Dy M; Sheehan K; Schreiber R; Grau G; Bluestone J; Bach JF; Chatenoud L
    Eur J Immunol; 1991 Oct; 21(10):2349-53. PubMed ID: 1833202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
    Damle NK; Doyle LV
    Lymphokine Res; 1989; 8(2):85-97. PubMed ID: 2525210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
    Kelso A
    J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired T cell proliferation in acute dengue infection.
    Mathew A; Kurane I; Green S; Vaughn DW; Kalayanarooj S; Suntayakorn S; Ennis FA; Rothman AL
    J Immunol; 1999 May; 162(9):5609-15. PubMed ID: 10228044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.
    Lorenz HM; Antoni C; Valerius T; Repp R; Grünke M; Schwerdtner N; Nüsslein H; Woody J; Kalden JR; Manger B
    J Immunol; 1996 Feb; 156(4):1646-53. PubMed ID: 8568271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The influence of methylprednisolone on the ability of CD4
    Todosenko NM; Khaziakhmatova OG; Yurova KA; Malinina IP; Litvinova LS
    Biomed Khim; 2017 May; 63(3):255-265. PubMed ID: 28781259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for IL-2 independent proliferation in human T cells.
    Laing TJ; Weiss A
    J Immunol; 1988 Feb; 140(4):1056-62. PubMed ID: 2830333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
    Ceuppens JL; Baroja ML
    J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-2-resistant hyporesponsiveness induced by CD4 mAbs in OKT3-activated human T cells is reversed by CD45RA triggering.
    Robinet E; Fournel S; Fatmi A; Revillard JP
    Cell Immunol; 1996 Jan; 167(1):1-7. PubMed ID: 8548832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals.
    Landis RC; Friedman ML; Fisher RI; Ellis TM
    J Immunol; 1991 Jan; 146(1):128-35. PubMed ID: 1824588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation.
    Hackett RJ; Davis LS; Lipsky PE
    J Immunol; 1988 Apr; 140(8):2639-44. PubMed ID: 2965728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3.
    Steffen M; Ottmann OG; Moore MA
    J Immunol; 1988 Apr; 140(8):2621-4. PubMed ID: 3258616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
    Geppert TD; Lipsky PE
    J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.